Current perspectives in mesenchymal stem cell therapies for osteoarthritis

Area of Science:

• Orthopedics and Regenerative Medicine
• Biotechnology and Tissue Engineering

Background:

• Osteoarthritis (OA) is a degenerative joint disease causing cartilage destruction, pain, and reduced mobility, particularly in aging populations.
• Conventional OA treatments are often ineffective in halting disease progression, frequently necessitating surgical intervention.
• Tissue engineering with mesenchymal stem cells (MSCs) has emerged as a novel therapeutic approach for OA.

Purpose of the Study:

• To review the historical applications of MSCs in cartilage regeneration.
• To evaluate current trends and emerging strategies in MSC-based OA treatment.
• To provide an overview of MSCs' potential in treating osteoarthritis.

Main Methods:

• Review of scientific literature on mesenchymal stem cells and osteoarthritis.
• Analysis of historical and current therapeutic approaches using MSCs for cartilage repair.
• Evaluation of different MSC delivery methods, including surgical implantation and intra-articular injection.

Main Results:

• Early MSC applications involved cell-rich matrix implantation during open surgery, leading to hyaline-like cartilage formation.
• Current trends focus on direct intra-articular injections of MSCs into affected joints.
• Both autologous and allogeneic MSCs have been utilized, with ongoing research into optimal cell sources and delivery.

Conclusions:

• Mesenchymal stem cells represent a significant advancement in osteoarthritis management.
• The shift towards intra-articular injections signifies a move towards less invasive and potentially more effective MSC-based therapies.
• Further research and clinical evaluation are crucial to optimize MSC-based treatments for osteoarthritis.